Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-micelle curcumin plus triamcinolone acetonide for oral lichen planus
IRCT20190523043678N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin and triamcinolone acetonide in oral lichen planus (OLP), sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2018; status: completed.
02
Drugs
curcumintriamcinolone acetonide
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20190523043678N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190523043678N1.